Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02RJY
|
|||
| Former ID |
DCL001078
|
|||
| Drug Name |
PHA-739358
|
|||
| Synonyms |
Danusertib; PHA 739358; Danusertib, PHA-739358; (R)-N-(5-(2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide; 5-Amido-pyrrolopyrazole 9d
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 2 | [1], [2] | |
| Company |
Pfizer; Nerviano
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H30N6O3
|
|||
| Canonical SMILES |
CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC
|
|||
| InChI |
1S/C26H30N6O3/c1-30-12-14-31(15-13-30)20-10-8-19(9-11-20)25(33)27-24-21-16-32(17-22(21)28-29-24)26(34)23(35-2)18-6-4-3-5-7-18/h3-11,23H,12-17H2,1-2H3,(H2,27,28,29,33)/t23-/m1/s1
|
|||
| InChIKey |
XKFTZKGMDDZMJI-HSZRJFAPSA-N
|
|||
| CAS Number |
CAS 827318-97-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
16541138, 23585151, 42521925, 46394298, 46513412, 57304411, 77307760, 93581266, 99373541, 99436985, 103573135, 124757005, 125163810, 126626959, 126634887, 126665979, 126730902, 131480684, 134964424, 135261930, 136340130, 136367305, 136367975, 136920406, 137147906, 137276047, 140478603, 143499036, 144115881, 152036110, 152134559, 152164575, 152186748, 152239915, 152258104, 152344035, 160646943, 162011705, 162037440, 162202553, 163109117, 164193992, 164838824, 174006483, 177748769, 180177283, 188899502, 198940281, 223682527, 223704702
|
|||
| ChEBI ID |
CHEBI:94490
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7937). | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025382) | |||
| REF 3 | Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition. J Med Chem. 2005 Apr 21;48(8):3080-4. | |||
| REF 4 | Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov. 2009 Jul;8(7):547-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.